I’m barely now seeing your reply my bad. But ahh okay , there stock has been beaten up this year , but I do like the idea of having some exposure to the GLP-1 market and I didn’t know they had they only fda approved oral medication. You like them better than Lilly or Nvo simply has more room to grow?

---

NVO is so criminally undervalued but that fucking mango is cucking me hard every time he opens his mouth.

---

Hmm that's an interesting prediction After all, NVO and LLY are both building massive US manufacturing, so they're already in line with the trade policy. Kill the compounders and they might agree to a deal - win win for Trump and NVO / LLY, lose lose for HIMS

---

NVO to 0. fucking hate that stock

---

#OZEMPIC ORAL PILLS FDA APPROVAL $NVO

---

LLY and NVO don't have a choice Either give Mango the price he wants or let the compounders eat their profits.

---

Holy shit NVO bag holders got rekt. This is the moment they were waiting for lmaoo

---

NVO will be obliterated.

---

Because it makes tons of profit, pays dividends, and constantly coming out with new medications and own one of the largest weight losing drugs in the world. Just tonight they got approved another medication Novo Nordisk announces FDA approval of Rybelsus Novo Nordisk (NVO) announced that the U.S. FDA has approved Rybelsus, the only oral GLP-1 medication available, for reducing the risk of major adverse cardiovascular events such as cardiovascular death, heart attack, or stroke in adults with type 2 diabetes who are at high risk for these events, whether they’ve had a prior CV event or not. Results of the SOUL trial reinforce the clinical profile of the semaglutide molecule, which has been studied across a variety of therapeutic areas.

---

Why Nvo?

---